BOSTON SCIENTIFIC CORPORATION Funds and ETFs Boston Scientific Corporation
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.43 USD | +1.21% |
|
+2.17% | +27.02% |
| May. 02 | Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing | MT |
| May. 02 | Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing | MT |
ETFs positioned on Boston Scientific Corporation
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.19% | 0 M€ | +10.94% | - | |
| 0.18% | 284 M€ | -.--% | ||
| 0.18% | 1 M€ | -.--% | ||
| 0.18% | 206 M€ | -.--% | ||
| 0.18% | 0 M€ | +1.14% | - | |
| 0.17% | 786 M€ | -.--% | ||
| 0.17% | 23 M€ | -.--% | - | |
| 0.16% | 0 M€ | +18.57% | - | |
| 0.16% | 0 M€ | +11.74% | - | |
| 0.15% | 14 M€ | +16.19% | - | |
| 0.15% | 1 M€ | +3.03% | - | |
| 0.14% | 205 M€ | -.--% | ||
| 0.13% | 1,166 M€ | +0.26% | - | |
| 0.13% | 607 M€ | +0.05% | - | |
| 0.11% | 0 M€ | +3.48% | - | |
| 0.11% | 0 M€ | +17.22% | ||
| 0.10% | 0 M€ | +6.11% | - | |
| 0.09% | 0 M€ | +8.16% | - | |
| 0.09% | 1,006 M€ | -.--% | - | |
| 0.09% | 414 M€ | +11.37% | - | |
| 0.09% | 0 M€ | 0.00% | - | |
| 0.08% | 0 M€ | +7.51% | - | |
| 0.07% | 0 M€ | +8.81% |
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Calendar
2024-05-14
- BofA Securities Health Care Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
73.43
USD
Average target price
81.16
USD
Spread / Average Target
+10.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +27.02% | 108B | |
| +7.93% | 219B | |
| +7.53% | 184B | |
| +15.20% | 138B | |
| -1.14% | 62.54B | |
| +7.23% | 52.22B | |
| +12.58% | 51.73B | |
| +1.61% | 41.4B | |
| +5.32% | 37.17B | |
| +25.66% | 31.76B |
- Stock Market
- Equities
- BSX Stock
- Funds and ETFs Boston Scientific Corporation